WNK1
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) |
| ||||||||
RefSeq (protein) | |||||||||
Location (UCSC) | Chr 12: 0.75 – 0.91 Mb | Chr 6: 119.92 – 120.04 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
WNK (lysine deficient protein kinase 1), also known as WNK1, is an enzyme that is encoded by the WNK1
Structure
The WNK1
Function
The WNK1 gene encodes a
Sodium reabsorption
In the
Potassium secretion
WNK1 regulates
Cell volume regulation
The NKCC1/2 cotransporters are regulated by intracellular Cl− concentration.[9] Studies point to WNK1 as key effector that couples Cl− concentration to NKCC1/2 function.[5][9] In hypertonic (high extracellular Cl− ) conditions that trigger cell shrinkage, an unknown mechanism upregulates WNK1 expression to counteract the volume loss.[5] The increased WNK1 leads to activation of SPAK/OSR1 that activate NKCC1/2 via subsequent phosphorylation.[5][9] NKCC1/2 will promote the influx of Na+, K+, and Cl− ions into the cell thereby causing the flow of water into the cell.[5] In the reverse circumstances, where hypotonic (low extracellular Cl− ) conditions induce cell swelling, WNK1 is inhibited.[5] Another cotransporter, KCC is inactive when phosphorylated; without activated WNK1, KCC does not undergo phosphorylation and can activate.[5] The cotransporter will promote the efflux of K+ and Cl− ions and cause the flow of water out of the cell to combat swelling.[5]
WNK1 in the brain
In the mature brain, the
Regulation of WNK1
The concentrations of Cl− ions and K+ ion play a major role in regulating WNK1 activity.[5][9] In the DCT, the plasma concentration of K+ ion is thought to impact the concentration Cl− ions within the nephron.[5][9] High plasma K+ concentration down regulates WNK1 activity and prevents Cl− ion from entering the nephron via the NCC.[5][9] The opposite occurs when plasma K+ concentration is low; increased WNK1 activity boosts NCC activity promoting reabsorption of Cl− ions.[5][9] When there is an abundance of Cl− ions within the nephron, WNK1 activity is inhibited by the binding of a Cl− ion to WNK1's catalytic domain.[5][9]
Furthermore, WNK1 and WNK4 may interact to form heterodimers that inhibit WNK1 function.[7][6] WNK4 release from the heterodimer allows WNK1 monomer to bind another WNK1 monomer to promote activation.[6][7] WNK1 function can also be inhibited if WNK1 is degraded. There are two enzymes responsible for WNK1 ubiquitination, kelch like 3 (KLHL3) and cullin 3 (CUL3).[7][6][10] KLHL3 serves as an adaptor protein that promotes the interaction between WNK1 and Cullin3, which is in a complex containing an E3 ubiquitin ligase that attaches the ubiquitin molecules to WNK1.[7] The ubiquitinated WNK1 will subsequently undergo proteasomal degradation.[7][6][10]
Clinical significance
WNK1 has
Comparative genomics
The gene belongs to a group of four related protein kinases (WNK1, WNK2, WNK3, WNK4).[5][7][8]
Homologs of this protein have been found in
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000060237 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000045962 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ PMID 28178566.
- ^ PMID 26863326.
- ^ PMID 25788573.
- ^ S2CID 22087578.
- ^ PMID 25904388.
- ^ S2CID 206672635.
- S2CID 3938880.